Riverbridge Partners LLC Has $121.33 Million Holdings in The Ensign Group, Inc. $ENSG

Riverbridge Partners LLC lowered its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 8.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 696,510 shares of the company’s stock after selling 66,622 shares during the period. The Ensign Group accounts for 2.3% of Riverbridge Partners LLC’s holdings, making the stock its 9th largest holding. Riverbridge Partners LLC’s holdings in The Ensign Group were worth $121,332,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Legacy Wealth Asset Management LLC boosted its holdings in shares of The Ensign Group by 0.8% during the 4th quarter. Legacy Wealth Asset Management LLC now owns 11,404 shares of the company’s stock valued at $1,987,000 after acquiring an additional 95 shares in the last quarter. SG Americas Securities LLC grew its position in The Ensign Group by 70.2% during the 4th quarter. SG Americas Securities LLC now owns 38,029 shares of the company’s stock worth $6,625,000 after acquiring an additional 15,683 shares during the last quarter. Harbor Investment Advisory LLC increased its holdings in The Ensign Group by 125.6% in the 4th quarter. Harbor Investment Advisory LLC now owns 194 shares of the company’s stock worth $34,000 after purchasing an additional 108 shares in the last quarter. Park Avenue Securities LLC increased its holdings in The Ensign Group by 4.7% in the 4th quarter. Park Avenue Securities LLC now owns 12,652 shares of the company’s stock worth $2,204,000 after purchasing an additional 567 shares in the last quarter. Finally, GAMMA Investing LLC raised its position in The Ensign Group by 10.3% in the fourth quarter. GAMMA Investing LLC now owns 3,923 shares of the company’s stock valued at $683,000 after purchasing an additional 366 shares during the last quarter. Institutional investors own 96.12% of the company’s stock.

Insiders Place Their Bets

In other The Ensign Group news, CFO Suzanne D. Snapper sold 4,573 shares of the stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $196.11, for a total transaction of $896,811.03. Following the transaction, the chief financial officer directly owned 272,889 shares in the company, valued at approximately $53,516,261.79. This represents a 1.65% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Daren Shaw sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $213.43, for a total transaction of $213,430.00. Following the sale, the director directly owned 23,726 shares of the company’s stock, valued at approximately $5,063,840.18. This trade represents a 4.04% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 17,073 shares of company stock valued at $3,333,390 in the last 90 days. Company insiders own 3.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on ENSG. Zacks Research upgraded The Ensign Group from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 26th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $222.00 price objective (up from $206.00) on shares of The Ensign Group in a report on Monday, February 9th. Truist Financial set a $215.00 target price on shares of The Ensign Group and gave the stock a “hold” rating in a research report on Friday, February 6th. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of The Ensign Group in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, The Ensign Group currently has an average rating of “Buy” and a consensus price target of $204.60.

The Ensign Group Stock Performance

Shares of ENSG opened at $201.99 on Friday. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $11.70 billion, a P/E ratio of 34.59, a price-to-earnings-growth ratio of 2.00 and a beta of 0.83. The firm’s fifty day simple moving average is $198.97 and its two-hundred day simple moving average is $184.89. The Ensign Group, Inc. has a 12 month low of $118.73 and a 12 month high of $218.00.

The Ensign Group (NASDAQ:ENSG) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.07. The firm had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.37 billion. The Ensign Group had a return on equity of 16.76% and a net margin of 6.80%.The business’s quarterly revenue was up 20.2% on a year-over-year basis. During the same period last year, the company posted $1.49 EPS. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. As a group, analysts predict that The Ensign Group, Inc. will post 5.59 EPS for the current year.

The Ensign Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be issued a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date is Tuesday, March 31st. The Ensign Group’s payout ratio is presently 4.45%.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.